This would suggest that, for many tumor antigens, central tolerance of CD4+ T cells against thymus-expressed antigens may not necessarily have a negative impact on shaping the anti-tumor B cell or CD8+ T cell repertoire. This evidence concerns the gene CD8A and neoplasm.